Ascendis Pharma ADR (ASND)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
| 09-2023 | 06-2023 | 03-2023 | 12-2022 | 09-2022 | |
| Assets | |||||
| Current Assets | |||||
| Cash & Cash Equivalents | 480,276 | 429,860 | 538,075 | 468,607 | 612,710 |
| Marketable Securities | 15,417 | 40,214 | 90,659 | 306,269 | 313,723 |
| Receivables | 54,456 | 38,926 | 37,097 | 27,000 | 21,704 |
| Inventories | 205,851 | 183,099 | 161,922 | 137,677 | 104,724 |
| TOTAL | $797,716 | $738,940 | $869,288 | $972,969 | $1,087,677 |
| Non-Current Assets | |||||
| PPE Net | 136,632 | 136,695 | 137,140 | 136,015 | 140,348 |
| Investments And Advances | 8,834 | 15,387 | 23,578 | 32,055 | 47,680 |
| Intangibles | 4,892 | 5,022 | 5,063 | 5,087 | 4,975 |
| Other Non-Current Assets | 2,331 | 2,253 | 2,130 | 2,023 | 1,909 |
| TOTAL | $152,690 | $159,357 | $167,911 | $175,179 | $194,911 |
| Total Assets | $950,405 | $898,297 | $1,037,198 | $1,148,148 | $1,282,589 |
| Liabilities | |||||
| Current Liabilities | |||||
| Short Term Debt | 12,869 | 28,965 | 27,257 | 26,784 | 20,241 |
| Accounts payable and accrued liabilities | 132,297 | 133,160 | 141,086 | 106,447 | 86,722 |
| Other current liabilities | 63,640 | 41,236 | 37,201 | 41,436 | 36,777 |
| TOTAL | $231,566 | $209,656 | $212,921 | $180,451 | $143,866 |
| Non-Current Liabilities | |||||
| Long Term Debt | 598,057 | 522,709 | 515,219 | 508,842 | 536,984 |
| Other Non-Current Liabilities | 200,706 | 95,229 | 129,585 | 181,391 | 146,935 |
| TOTAL | $798,764 | $617,938 | $644,804 | $690,233 | $683,919 |
| Total Liabilities | $1,030,329 | $827,594 | $857,725 | $870,685 | $827,786 |
| Shareholders' Equity | |||||
| Common Shares | 8,426 | 8,395 | 8,263 | 8,086 | 7,713 |
| Retained earnings | -2,399,171 | -2,245,429 | -2,101,416 | -1,960,215 | -1,802,516 |
| Other shareholders' equity | 2,254 | 1,636 | 2,701 | 3,479 | 253,666 |
| TOTAL | $-79,925 | $70,703 | $179,474 | $277,463 | $454,803 |
| Total Liabilities And Equity | $950,405 | $898,297 | $1,037,199 | $1,148,148 | $1,282,589 |